sulfadoxine has been researched along with asparagine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curtis, J; Duraisingh, MT; Warhurst, DC | 1 |
| Abdul-Ghani, R; Allam, AF; Farag, HF; Shawky, SM | 1 |
1 trial(s) available for sulfadoxine and asparagine
| Article | Year |
|---|---|
In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment.
Topics: Amino Acid Sequence; Animals; Antimalarials; Arginine; Asparagine; Child; Dapsone; Dihydropteroate Synthase; Drug Therapy, Combination; Genes, Protozoan; Genetic Variation; Genotype; Humans; Isoleucine; Malaria, Falciparum; Plasmodium falciparum; Point Mutation; Polymerase Chain Reaction; Proguanil; Pyrimethamine; Sulfadoxine | 1998 |
1 other study(ies) available for sulfadoxine and asparagine
| Article | Year |
|---|---|
Prevailing Plasmodium falciparum dihydrofolate reductase 108-asparagine in Hodeidah, Yemen: a questionable sulfadoxine-pyrimethamine partner within the artemisinin-based combination therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Asparagine; Child; Child, Preschool; Cross-Sectional Studies; DNA, Protozoan; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Gene Frequency; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Middle Aged; Mutation, Missense; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Yemen; Young Adult | 2014 |